CIMADAMORE, ALESSIA
CIMADAMORE, ALESSIA
The molecular characteristics of non‐clear cell renal cell carcinoma: What’s the story morning glory?
2021 Marchetti A.; Rosellini M.; Mollica V.; Rizzo A.; Tassinari E.; Nuvola G.; Cimadamore A.; Santoni M.; Fiorentino M.; Montironi R.; Massari F.
Towards a new WHO classification of renal cell tumor: What the clinician needs to know-a narrative review
2021 Cimadamore A.; Cheng L.; Scarpelli M.; Massari F.; Mollica V.; Santoni M.; Lopez-Beltran A.; Montironi R.; Moch H.
The human microbiota and prostate cancer: Friend or foe?
2019 Massari F.; Mollica V.; Di Nunno V.; Gatto L.; Santoni M.; Scarpelli M.; Cimadamore A.; Lopez-Beltran A.; Cheng L.; Battelli N.; Montironi R.; Brandi G.
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer
2018 Di Nunno, Vincenzo; Cimadamore, Alessia; Santoni, Matteo; Scarpelli, Marina; Fiorentino, Michelangelo; Ciccarese, Chiara; Iacovelli, Roberto; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Montironi, Rodolfo*
Emerging Molecular Technologies in Genitourinary Tumors
2018 Giunchi, Francesca; Cimadamore, Alessia; Fiorentino, Michelangelo
New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen
2018 Cimadamore A.; Cheng M.; Santoni M.; Lopez-Beltran A.; Battelli N.; Massari F.; Galosi A.B.; Scarpelli M.; Montironi R.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| The molecular characteristics of non‐clear cell renal cell carcinoma: What’s the story morning glory? | Marchetti A.; Rosellini M.; Mollica V.; Rizzo A.; Tassinari E.; Nuvola G.; Cimadamore A.; Santoni... M.; Fiorentino M.; Montironi R.; Massari F. | 2021-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-22-06237-v2.pdf |
| Towards a new WHO classification of renal cell tumor: What the clinician needs to know-a narrative review | Cimadamore A.; Cheng L.; Scarpelli M.; Massari F.; Mollica V.; Santoni M.; Lopez-Beltran A.; Mont...ironi R.; Moch H. | 2021-01-01 | TRANSLATIONAL ANDROLOGY AND UROLOGY | - | 1.01 Articolo in rivista | TAU 2021 [WHO].pdf |
| The human microbiota and prostate cancer: Friend or foe? | Massari F.; Mollica V.; Di Nunno V.; Gatto L.; Santoni M.; Scarpelli M.; Cimadamore A.; Lopez-Bel...tran A.; Cheng L.; Battelli N.; Montironi R.; Brandi G. | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-11-00459.pdf |
| Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer | Di Nunno, Vincenzo; Cimadamore, Alessia; Santoni, Matteo; Scarpelli, Marina; Fiorentino, Michelan...gelo; Ciccarese, Chiara; Iacovelli, Roberto; Cheng, Liang; Lopez-Beltran, Antonio; Massari, Francesco; Montironi, Rodolfo* | 2018-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Emerging Molecular Technologies in Genitourinary Tumors | Giunchi, Francesca; Cimadamore, Alessia; Fiorentino, Michelangelo | 2018-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-08-00489.pdf |
| New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen | Cimadamore A.; Cheng M.; Santoni M.; Lopez-Beltran A.; Battelli N.; Massari F.; Galosi A.B.; Scar...pelli M.; Montironi R. | 2018-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | Fron Oncol 2018 [PSA].pdf.pdf |